Insider transactions

EDGAR

Ernexa Therapeutics Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-21.

Open-market purchases (code P)
1 transactions, 4,000,000 shares
Sum of shares × price per share: 2,000,000
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–10 of 10

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-08-31 Filed 2026-09-01Polinsky David Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to buy) — underlying Common Stock (5,083) — exercise price 4.57
Acquired (A)5,0830—5,083Direct (D) No
F1
  • F1 Represents options to purchase shares of the registrant's common stock in lieu of prorated director's cash compensation for 2026 pursuant to the Director's Compensation Plan effective August 15, 2026, granted under the Issuer's 2026 Omnibus Equity Incentive Plan. Subject to continued service, 100% of the stock options will vest on December 31, 2026.
Open filing 0001493152-26-041133 Read from the filing’s XML Dispute this row
2026-08-31 Filed 2026-09-01Cicala Peter Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to buy) — underlying Common Stock (5,943) — exercise price 4.57
Acquired (A)5,9430—5,943Direct (D) No
F1
  • F1 Subject to continued service, one-third of the shares underlying the stock option will vest on the first anniversary of the grant date, and the remaining shares underlying the stock option will vest in 24 substantially equal monthly installments thereafter.
Open filing 0001493152-26-041135 Read from the filing’s XML Dispute this row
2026-08-31 Filed 2026-09-01Cicala Peter Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to buy) — underlying Common Stock (5,083) — exercise price 4.57
Acquired (A)5,0830—5,083Direct (D) No
F2
  • F2 Represents options to purchase shares of the registrant's common stock in lieu of prorated director's cash compensation for 2026 pursuant to the Director's Compensation Plan effective August 15, 2026, granted under the Issuer's 2026 Omnibus Equity Incentive Plan. Subject to continued service, 100% of the stock options will vest on December 31, 2026.
Open filing 0001493152-26-041135 Read from the filing’s XML Dispute this row
2026-08-31 Filed 2026-09-01Ratner Elena Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to buy) — underlying Common Stock (5,944) — exercise price 4.57
Acquired (A)5,9440—5,944Direct (D) No
F1
  • F1 Subject to continued service, one-third of the shares underlying the stock option will vest on the first anniversary of the grant date, and the remaining shares underlying the stock option will vest in 24 substantially equal monthly installments thereafter.
Open filing 0001493152-26-041131 Read from the filing’s XML Dispute this row
2026-08-31 Filed 2026-09-01Bristol James Arthur Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to buy) — underlying Common Stock (8,320) — exercise price 4.57
Acquired (A)8,3200—8,320Direct (D) No
F1
  • F1 Subject to continued service, one-third of the shares underlying the stock option will vest on the first anniversary of the grant date, and the remaining shares underlying the stock option will vest in 24 substantially equal monthly installments thereafter.
Open filing 0001493152-26-041137 Read from the filing’s XML Dispute this row
2026-08-31 Filed 2026-09-01Bristol James Arthur Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to buy) — underlying Common Stock (5,083) — exercise price 4.57
Acquired (A)5,0830—5,083Direct (D) No
F2
  • F2 Represents options to purchase shares of the registrant's common stock in lieu of prorated director's cash compensation for 2026 pursuant to the Director's Compensation Plan effective August 15, 2026, granted under the Issuer's 2026 Omnibus Equity Incentive Plan. Subject to continued service, 100% of the stock options will vest on December 31, 2026.
Open filing 0001493152-26-041137 Read from the filing’s XML Dispute this row
2026-08-31 Filed 2026-09-01Wexler William A. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to buy) — underlying Common Stock (5,943) — exercise price 4.57
Acquired (A)5,9430—5,943Direct (D) No
F1
  • F1 Subject to continued service, one-third of the shares underlying the stock option will vest on the first anniversary of the grant date, and the remaining shares underlying the stock option will vest in 24 substantially equal monthly installments thereafter.
Open filing 0001493152-26-041132 Read from the filing’s XML Dispute this row
2026-08-31 Filed 2026-09-01Luther Sanjeev Director · Officer: President and CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (118,848) — exercise price 4.57
Acquired (A)118,8480—118,848Direct (D) No
F1
  • F1 Subject to continued service, one-third of the shares underlying the stock option will vest on the first anniversary of the grant date, and the remaining shares underlying the stock option will vest in 24 substantially equal monthly installments thereafter.
Open filing 0001493152-26-041130 Read from the filing’s XML Dispute this row
2026-02-10 Filed 2026-02-17Cherington Charles 10% owner
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)4,000,0000.50
2,000,000

Derived: shares × price per share. Exact value 2000000.00.

6,779,440Direct (D) No
F1, F2
  • F1 These shares and warrants were purchased by the reporting person in the Issuer's follow-on offering pursuant to a prospectus supplement dated February 6, 2026, which closed on February 10, 2026.
  • F2 The combined purchase price in the Offering per share of Common Stock and accompanying warrant was $0.50.
Open filing 0001104659-26-016680 Read from the filing’s XML Dispute this row
2026-02-10 Filed 2026-02-17Cherington Charles 10% owner
P

Open market or private purchase of non-derivative or derivative security

Derivative security: Warrants to Purchase Common Stock — underlying Common Stock (4,000,000) — exercise price 0.68
Acquired (A)4,000,000——4,000,000Direct (D) No
F1, F2, F3
  • F1 These shares and warrants were purchased by the reporting person in the Issuer's follow-on offering pursuant to a prospectus supplement dated February 6, 2026, which closed on February 10, 2026.
  • F2 The combined purchase price in the Offering per share of Common Stock and accompanying warrant was $0.50.
  • F3 The warrants will expire on the earlier of (i) February 10, 2031 or (ii) the 180th calendar day following the public release by the Company of clinical trial data from the first cohort of the Phase 1 study of ERNA-101.
Open filing 0001104659-26-016680 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,935 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,178 filings read.

Showing 1–22 of 22

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
Bleichroeder LP 2,000,000 SH63,400 dollarsUnchanged Prior quarter: 2,000,000Open filing 0001420506-26-002662 Filed 2026-11-13 Dispute this row
HEIGHTS CAPITAL MANAGEMENT, INC Partly reported under another manager400,000 SH14,000 dollarsUnchanged Prior quarter: 400,000Open filing 0001081698-26-000009 Filed 2026-11-16 Dispute this row
ARMISTICE CAPITAL, LLC 160,000 SH5,072 dollarsUnchanged Prior quarter: 160,000Open filing 0001315863-26-000784 Filed 2026-11-16 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Partly reported under another manager158,456 SH5,546 dollarsHigher by 100,566 Prior quarter: 57,890Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
Clear Street Group Inc. 150,679 SH4,777 dollarsHigher by 1,180 Prior quarter: 149,499Open filing 0001881567-26-000006 Filed 2026-11-16 Dispute this row
Warberg Asset Management LLC 60,359 SH1,913 dollarsLower by 9,071 Prior quarter: 69,430Open filing 0001597506-26-000004 Filed 2026-11-02 Dispute this row
HRT FINANCIAL LP 22,346 SH0 dollarsNot in the prior quarter’s filings read Open filing 0001475597-26-000249 Filed 2026-11-13 Dispute this row
Corient Private Wealth LP 17,461 SH55,876 dollarsNot in the prior quarter’s filings read Open filing 0001948780-26-000012 Filed 2026-11-16 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager16,077 SH51,446 dollarsNot in the prior quarter’s filings read Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
VANGUARD FIDUCIARY TRUST CO 8,336 SH26,675 dollarsUnchanged Prior quarter: 8,336Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 5,684 SH18,189 dollarsUnchanged Prior quarter: 5,684Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
Tradewinds Capital Management, LLC 4,609 SH14,749 dollarsHigher by 4,248 Prior quarter: 361Open filing 0001616026-26-000008 Filed 2026-10-23 Dispute this row
Tower Research Capital LLC (TRC) Partly reported under another manager1,552 SH4,966 dollarsNot in the prior quarter’s filings read Open filing 0001533421-26-000010 Filed 2026-11-16 Dispute this row
MORGAN STANLEY Partly reported under another manager200 SH640 dollarsNot in the prior quarter’s filings read Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
CITIGROUP INC Partly reported under another manager102 SH326 dollarsNot in the prior quarter’s filings read Open filing 0000831001-26-000052 Filed 2026-11-04 Dispute this row
BlackRock, Inc. Partly reported under another manager33 SH106 dollarsUnchanged Prior quarter: 33Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
UBS Group AG Partly reported under another manager19 SH61 dollarsNot in the prior quarter’s filings read Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
ASSETMARK, INC 5 SH16 dollarsUnchanged Prior quarter: 5Open filing 0001344551-26-000010 Filed 2026-10-21 Dispute this row
BNP PARIBAS FINANCIAL MARKETS Partly reported under another manager1 SH3 dollarsUnchanged Prior quarter: 1Open filing 0001166588-26-000012 Filed 2026-11-12 Dispute this row
Dauntless Investment Group, LLC 1 SH3 dollarsLower by 5,999 Prior quarter: 6,000Open filing 0002071844-26-001894 Filed 2026-11-16 Dispute this row
SBI Securities Co., Ltd. 1 SH3 dollarsUnchanged Prior quarter: 1Open filing 0001851815-26-000004 Filed 2026-10-22 Dispute this row
Steward Partners Investment Advisory, LLC 0 SH1 dollarsUnchanged Prior quarter: 0Open filing 0001723397-26-000006 Filed 2026-11-13 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • CITADEL ADVISORS LLC 15,104 SH
  • Activest Wealth Management 0 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Bleichroeder LP Common Shares4.6780,00009/30/2026 Filed 2026-11-10SCHEDULE 13G/AAmendment 1Open filing 0001420506-26-002563 Dispute this row
Bleichroeder Holdings LLC Common Shares4.6780,00009/30/2026 Filed 2026-11-10SCHEDULE 13G/AAmendment 1Open filing 0001420506-26-002563 Dispute this row
Andrew Gundlach Common Shares4.6780,00009/30/2026 Filed 2026-11-10SCHEDULE 13G/AAmendment 1Open filing 0001420506-26-002563 Dispute this row
Freebird Partners LP Common Stock, par value $0.005 per share7.0119,01508/05/2026 Filed 2026-10-30SCHEDULE 13G/AAmendment 7Open filing 0001193125-26-441302 Dispute this row
Freebird Investments LLC Common Stock, par value $0.005 per share7.0119,01508/05/2026 Filed 2026-10-30SCHEDULE 13G/AAmendment 7Open filing 0001193125-26-441302 Dispute this row
Curtis Huff Common Stock, par value $0.005 per share7.0119,01508/05/2026 Filed 2026-10-30SCHEDULE 13G/AAmendment 7Open filing 0001193125-26-441302 Dispute this row
Clear Street LLC Common Stock0.00.0005/05/2026 Filed 2026-05-20SCHEDULE 13G/AAmendment 1Open filing 0001708828-26-000225 Dispute this row
Clear Street LLC Common Stock12.8149,499.0005/05/2026 Filed 2026-05-14SCHEDULE 13GOpen filing 0001708828-26-000185 Dispute this row
Bleichroeder LP Common Shares6.8680,00003/31/2026 Filed 2026-05-14SCHEDULE 13GOpen filing 0001171520-26-000096 Dispute this row
Bleichroeder Holdings LLC Common Shares6.8680,00003/31/2026 Filed 2026-05-14SCHEDULE 13GOpen filing 0001171520-26-000096 Dispute this row
Andrew Gundlach Common Shares6.8680,00003/31/2026 Filed 2026-05-14SCHEDULE 13GOpen filing 0001171520-26-000096 Dispute this row
John D. Halpern Common Stock, par value $0.005 per share5.666,75102/10/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 6Open filing 0001193125-26-227548 Dispute this row
Katherine H. Halpern Common Stock, par value $0.005 per share5.666,75102/10/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 6Open filing 0001193125-26-227548 Dispute this row
Freebird Partners LP Common Stock, par value $0.005 per share9.9120,41202/10/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 6Open filing 0001193125-26-227556 Dispute this row
Freebird Investments LLC Common Stock, par value $0.005 per share9.9120,41202/10/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 6Open filing 0001193125-26-227556 Dispute this row
Curtis Huff Common Stock, par value $0.005 per share9.9120,41202/10/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 6Open filing 0001193125-26-227556 Dispute this row
Shameek Konar Common Stock, par value $0.005 per share9.7118,342.0002/10/2026 Filed 2026-05-13SCHEDULE 13G/AAmendment 2Open filing 0001104659-26-060524 Dispute this row
Victoria Konar Common Stock, par value $0.005 per share9.7118,342.0002/10/2026 Filed 2026-05-13SCHEDULE 13G/AAmendment 2Open filing 0001104659-26-060524 Dispute this row
Regolith Capital Investments LP Common Stock, par value $0.005 per share9.7117,907.0002/10/2026 Filed 2026-05-13SCHEDULE 13G/AAmendment 2Open filing 0001104659-26-060524 Dispute this row
Charles Cherington Common Stock, par value $0.005 per share34.710,791,335.0002/10/2026 Filed 2026-02-17SCHEDULE 13D/AAmendment 8Open filing 0001104659-26-016685 Dispute this row
Freebird Partners LP Common Stock, par value $0.005 per share9.9786,04012/19/2025 Filed 2025-12-19SCHEDULE 13G/AAmendment 5Open filing 0001193125-25-326739 Dispute this row
Freebird Investments LLC Common Stock, par value $0.005 per share9.9786,04012/19/2025 Filed 2025-12-19SCHEDULE 13G/AAmendment 5Open filing 0001193125-25-326739 Dispute this row
Curtis Huff Common Stock, par value $0.005 per share9.9786,04012/19/2025 Filed 2025-12-19SCHEDULE 13G/AAmendment 5Open filing 0001193125-25-326739 Dispute this row
IAF, LLC Common Stock, par value $0.005 per share4.1315,779.0007/28/2025 Filed 2025-08-18SCHEDULE 13G/AAmendment 3Open filing 0001104659-25-079777 Dispute this row
Shameek Konar Common Stock, par value $0.005 per share7.12558,531.0006/30/2025 Filed 2025-12-16SCHEDULE 13G/AAmendment 1Open filing 0001104659-25-121683 Dispute this row
Victoria Konar Common Stock, par value $0.005 per share7.12558,531.0006/30/2025 Filed 2025-12-16SCHEDULE 13G/AAmendment 1Open filing 0001104659-25-121683 Dispute this row
Regolith Capital Investments LP Common Stock, par value $0.005 per share6.98547,668.0006/30/2025 Filed 2025-12-16SCHEDULE 13G/AAmendment 1Open filing 0001104659-25-121683 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,687,210 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015103,592
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,828

Filings made before the SEC required XML are listed, not extracted.

Back to Ernexa Therapeutics Inc.